These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 28806518)

  • 1. In Vivo Biosynthesized Zinc and Iron Oxide Nanoclusters for High Spatiotemporal Dual-Modality Bioimaging of Alzheimer's Disease.
    Lai L; Jiang X; Han S; Zhao C; Du T; Rehman FU; Zheng Y; Li X; Liu X; Jiang H; Wang X
    Langmuir; 2017 Sep; 33(36):9018-9024. PubMed ID: 28806518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo target bio-imaging of Alzheimer's disease by fluorescent zinc oxide nanoclusters.
    Lai L; Zhao C; Su M; Li X; Liu X; Jiang H; Amatore C; Wang X
    Biomater Sci; 2016 Jul; 4(7):1085-91. PubMed ID: 27229662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo characterization of several functionalized ultrasmall particles of iron oxide, vectorized against amyloid plaques and potentially able to cross the blood-brain barrier: toward earlier diagnosis of Alzheimer's disease by molecular imaging.
    Ansciaux E; Burtea C; Laurent S; Crombez D; Nonclercq D; Vander Elst L; Muller RN
    Contrast Media Mol Imaging; 2015; 10(3):211-24. PubMed ID: 25284012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
    Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F
    J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosynthesized Gold Nanoclusters and Iron Complexes as Scaffolds for Multimodal Cancer Bioimaging.
    Zhao C; Du T; Rehman FU; Lai L; Liu X; Jiang X; Li X; Chen Y; Zhang H; Sun Y; Luo S; Jiang H; Selke M; Wang X
    Small; 2016 Dec; 12(45):6255-6265. PubMed ID: 27672010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation by Magnetic Resonance Imaging of the Diagnostic Potential of a Heptapeptide-Functionalized Imaging Probe Targeted to Amyloid-β and Able to Cross the Blood-Brain Barrier.
    André S; Ansciaux E; Saidi E; Larbanoix L; Stanicki D; Nonclercq D; Vander Elst L; Laurent S; Muller RN; Burtea C
    J Alzheimers Dis; 2017; 60(4):1547-1565. PubMed ID: 29036827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease.
    Poduslo JF; Curran GL; Wengenack TM; Malester B; Duff K
    Neurobiol Dis; 2001 Aug; 8(4):555-67. PubMed ID: 11493021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dual magnetic resonance imaging/fluorescent contrast agent for Cathepsin-D detection.
    Ta R; Suchy M; Tam JH; Li AX; Martinez-Santiesteban FS; Scholl TJ; Hudson RH; Bartha R; Pasternak SH
    Contrast Media Mol Imaging; 2013; 8(2):127-39. PubMed ID: 23281285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinoline-n-butylcyanoacrylate-based nanoparticles for brain targeting for the diagnosis of Alzheimer's disease.
    Kulkarni PV; Roney CA; Antich PP; Bonte FJ; Raghu AV; Aminabhavi TM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(1):35-47. PubMed ID: 20049829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
    Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
    Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin-conjugated magnetic nanoparticles for detecting amyloid plaques in Alzheimer's disease mice using magnetic resonance imaging (MRI).
    Cheng KK; Chan PS; Fan S; Kwan SM; Yeung KL; Wáng YX; Chow AH; Wu EX; Baum L
    Biomaterials; 2015 Mar; 44():155-72. PubMed ID: 25617135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metal dyshomeostasis and oxidative stress in Alzheimer's disease.
    Greenough MA; Camakaris J; Bush AI
    Neurochem Int; 2013 Apr; 62(5):540-55. PubMed ID: 22982299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood-Brain Barrier Penetrating Biologic TNF-α Inhibitor for Alzheimer's Disease.
    Chang R; Knox J; Chang J; Derbedrossian A; Vasilevko V; Cribbs D; Boado RJ; Pardridge WM; Sumbria RK
    Mol Pharm; 2017 Jul; 14(7):2340-2349. PubMed ID: 28514851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging.
    Wadghiri YZ; Sigurdsson EM; Sadowski M; Elliott JI; Li Y; Scholtzova H; Tang CY; Aguinaldo G; Pappolla M; Duff K; Wisniewski T; Turnbull DH
    Magn Reson Med; 2003 Aug; 50(2):293-302. PubMed ID: 12876705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-Time Multimodal Bioimaging of Cancer Cells and Exosomes through Biosynthesized Iridium and Iron Nanoclusters.
    Shaikh S; Rehman FU; Du T; Jiang H; Yin L; Wang X; Chai R
    ACS Appl Mater Interfaces; 2018 Aug; 10(31):26056-26063. PubMed ID: 30011179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential use of H102 peptide-loaded dual-functional nanoparticles in the treatment of Alzheimer's disease.
    Zhang C; Zheng X; Wan X; Shao X; Liu Q; Zhang Z; Zhang Q
    J Control Release; 2014 Oct; 192():317-24. PubMed ID: 25102404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of focused ultrasound-induced blood-brain barrier permeability in a mouse model of Alzheimer's disease using two-photon microscopy.
    Burgess A; Nhan T; Moffatt C; Klibanov AL; Hynynen K
    J Control Release; 2014 Oct; 192():243-8. PubMed ID: 25107692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery.
    Vilella A; Belletti D; Sauer AK; Hagmeyer S; Sarowar T; Masoni M; Stasiak N; Mulvihill JJE; Ruozi B; Forni F; Vandelli MA; Tosi G; Zoli M; Grabrucker AM
    J Trace Elem Med Biol; 2018 Sep; 49():210-221. PubMed ID: 29325805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nano in nano: Biosynthesized gold and iron nanoclusters cargo neoplastic exosomes for cancer status biomarking.
    Rehman FU; Du T; Shaikh S; Jiang X; Chen Y; Li X; Yi H; Hui J; Chen B; Selke M; Wang X
    Nanomedicine; 2018 Nov; 14(8):2619-2631. PubMed ID: 30130583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: in vitro and in vivo characterization.
    Sánchez-López E; Ettcheto M; Egea MA; Espina M; Cano A; Calpena AC; Camins A; Carmona N; Silva AM; Souto EB; García ML
    J Nanobiotechnology; 2018 Mar; 16(1):32. PubMed ID: 29587747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.